Optimizing strategies for the treatment of colorectal cancer in the biomarker era - Module 1

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the role of biomarkers in optimizing the treatment of colorectal cancer, and how biomarkers are shaping the evolving treatment landscape.  The experts Dr Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan Dr Chiara Cremolini, University of Pisa, Pisa, Italy Dr Rachel Riechelmann, AC Camargo Cancer Center, São Paulo, Brazil This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information please visit: https://touchoncologyime.org/pd-treatment-of-crc-in-the-biomarker-era/